- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
OneOncology Announces Dr Lee Schwartzberg as Its Chief Medical Officer
OneOncology has tapped Lee Schwartzberg, MD, medical director of West Cancer Center and Research Institute and professor of medicine at The University of Tennessee Health Science Center as its chief medical officer.
OneOncology has tapped Lee Schwartzberg, MD, medical director of West Cancer Center and Research Institute and professor of medicine at The University of Tennessee Health Science Center as its chief medical officer. In the position, Schwartzberg will serve as a link between OneOncology and its partners, demonstrating the shared, foundational commitment to a physician- and data-driven, technology-powered, patient-centered organization.
“I am thrilled to become the CMO for OneOncology because of the organization’s commitment to physician governance, leadership, and collaboration,” said Schwartzberg. “The combined clinical and operational acumen of our practices leveraged at national scale empowers our doctors to provide the best care to the patients they serve.”
What Will AI in Health Care Look Like in the Future?
July 10th 2025Artificial intelligence (AI) transforms oncology by enhancing clinical decision-making, improving patient outcomes, and shaping future health care training, as discussed by experts at Tennessee Oncology's “Tech Innovations in Community Oncology."
Read More
Practical Considerations for AI in Community Oncology
July 8th 2025Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining operations, while addressing challenges in data accuracy and equity, said speakers at the Tennessee Oncology “Tech Innovations in Community Oncology."
Read More
Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Read More
